It doesn’t have to end in tears- Repurposing drugs for ocular delivery

Jeremy Drummond’s ‘In My View’ piece is available to read in the latest edition of The Medicine Maker. You can read his opinion about how the eye is often missed when companies look into repurposing drugs. Do you agree?

JD in my view

“Pharma companies are closely scrutinizing existing products to discover if they have activity for new indications, possibly through new routes of delivery. Repurposing comes with challenges as developers must go back to the drawing board to optimize the product for its new purpose, which may require a new formulation or delivery mechanism. However, repurposing also has many advantages…”

You can find the full article at The Medicine Maker. Additionally, if you would like to discuss any of the opinions in the article please contact us here.

Back to News